Clinical Trials in Atlanta

Showing 16141-16160 of 19,805 trials

Depression-Diabetes Mechanisms: Urban African Americans

NCT00209170

African-Americans suffer from increased prevalence of both type 2 diabetes and diabetes complications, reflecting a combination of psychobehavioral factors as well as metabolic dysfunction. In this process, depression may contribute to both the genesis of type 2 diabetes (through impact on neurohormonal activation, inflammatory mediators, and insulin resistance), and difficulties in management (through decreased adherence to diet plans, medication, and scheduled appointments). The preliminary data from the Grady Diabetes Clinic indicates that depression may be common in African-Americans with diabetes, that depression is a factor in non-adherence, and that non-adherence leads to poor glycemic control - a direct cause of diabetes complications. What is not known is: how treatment of depression could lead to both neurohormonal and psychobiological improvement, with improved patient adherence and glycemic control.

DiabetesDepression

Emory University20 participantsStarted May 2004

Atlanta, Georgia, United States

COMPLETEDPhase 2< 1 mile

Combination of GTI-2040 and Cytarabine in the Treatment of Refractory and Relapsed Acute Myeloid Leukemia (AML)

NCT00565058

This is a Phase II trial conducted at multiple centers for evaluation of the pharmacodynamic activity and the overall response rate contributed by the combination agents of GTI-2040 and High Dose Cytarabine (HiDAC) in Refractory and Relapsed Acute Myeloid Leukemia (AML).

Acute Myeloid Leukemia

Aptose Biosciences Inc.27 participantsStarted Aug 2007

San Francisco, California, United States • San Francisco, California, United States • Atlanta, Georgia, United States +4 more locations

Depression-Diabetes Mechanisms: Urban African Americans

Combination of GTI-2040 and Cytarabine in the Treatment of Refractory and Relapsed Acute Myeloid Leukemia (AML)

Find Trials by Condition in Atlanta

Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Resistant aHUS

Spine Patient Outcomes Research Trial (SPORT) - Intervertebral Disc Herniation

Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

BAY 0 9867 Cipro Pediatric Use Study (QUIP)

A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis

A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation for Elective Awake Fiberoptic Intubation

Gastrointestinal Tolerance of Infant Formula

Study Evaluating the Pharmacokinetics of Keppra Extended Release (XR) in Children and Adults With Epilepsy

Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects

Pharmacokinetics of LCP-Tacro in Stable Kidney Transplant Patients

A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment

Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer

SynCardia Freedom Driver System Study

Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT)

A Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell Lymphomas

Safety and Efficacy Study of a Single Dose of NA-1 in Patients Undergoing Endovascular Repair of Ruptured Aneurysms

Follow-up Study After 11 Years of Patients Who Were Included in the BENEFIT Trial (304747) With a First Demyelinating Event Suggestive of Multiple Sclerosis

Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer